Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 4, 2020
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
Fri, May 1, 2020
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
[ Fri, May 01st 2020
] - WOPRAI
Steven Seedhouse Maintained (VKTX) at Strong Buy with Decreased Target to $25 on, May 1st, 2020
Steven Seedhouse of Raymond James, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Decreased Target from $41 to $25 on, May 1st, 2020.
Steven has made no other calls on VKTX in the last 4 months.
There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Steven's Rating of Hold.
This is the rating of the analyst that currently disagrees with Steven
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $18 on, Thursday, February 27th, 2020
